Lakeshore Hospital and Research Centre Unlisted Shares

About Company

Lakeshore Hospital & Research Centre is a multi-specialty, tertiary-care hospital located in Kochi, Kerala, managed by VPS Healthcare. It was incorporated on 4 April 1996 as a public limited company (CIN: U85110KL1996PLC010260). The hospital has ~ 650 beds, and offers a broad spectrum of specialties: cardiology, oncology, gastroenterology, neurology, organ transplant, and more. It is accredited by NABH and is known for high-quality care, advanced diagnostics, transplant capabilities, and medical education/research.

History & Ownership

• Founded by Dr. Philip Augustine.
• VPS Healthcare (led by Dr. V.P. Shamsheer) is deeply associated with Lakeshore; Shamsheer is listed on its board.
• According to 3adeal, promoter holding is ~77.78%.

Research & Training

• Lakeshore commits to clinical research and academic programs. 
• It runs postgraduate / DNB courses and has research infrastructure focused on diseases relevant to Kerala.

Financial Performance & Unlisted-Share Metrics

Business Results (FY22-23)

• Total operating income grew ~17% to ₹ 419 crore (from ~₹ 358 crore in FY22).
• PAT rose from ~₹ 42 crore in FY22 to ~₹ 57 crore in FY23.
• They saw ~343,876 out-patients and ~21,087 in-patients in FY23.
• They also did 53 liver transplants and 212 kidney transplants in FY23 (high success rate).
• Foreign patient volume rose substantially: ~20,047 foreign patients in FY23 vs ~6,008 in FY22.

Corporate / Balance Sheet

Paid-up capital: ₹ 100 crore.

• From its 2022-23 annual report: the company follows Ind-AS.
• According to 3adeal, as of 2025: net worth ~₹ 422.24 crore.

Strengths & Growth Drivers

• Strong Brand and Clinical Excellence: With high-end specialties and transplant capabilities, Lakeshore is a marquee hospital in Kerala.
• International Patient Reach: Growing inbound medical tourism, as seen in rising foreign patient numbers.
• Diversified Care Portfolio: Range of super-specialty services (oncology, transplant, cardiology) gives revenue breadth
• Backed by VPS Healthcare: Promoter strength + management credibility helps in scale, investments, and trust.
• Research & Training Focus: Having a teaching / research component adds prestige, recurring value and cost synergies.
• Healthy Financial Scale: Revenue growth + PAT growth in FY23 shows good financial health.

Risks & Challenges

• Unlisted-Share Liquidity Risk: As an unlisted hospital company, ease of exit or finding buyers may be limited.
• Regulatory Risk: Healthcare is subject to regulatory and ethical risks; transplant and high-cost procedures can attract scrutiny.
• Competition: Other large healthcare chains / tertiary hospitals in Kerala and South India can compete strongly.
• Cost Pressure: High cost of medical technology, staff and infrastructure (ICUs, OTs) can squeeze margins if not managed well.
• Volatility in Medical Tourism: Inbound/foreign patient inflow may vary with global conditions, affecting high-margin revenue.

Quick Summary

Lakeshore Hospital & Research Centre Ltd is a well-known, high-quality tertiary care hospital in Kochi under VPS Healthcare. It has demonstrated solid financial growth, strong clinical capabilities (especially in transplant), and a growing international patient base. As an unlisted healthcare company, it offers investors a way to participate in the high-growth hospital sector — but comes with liquidity risk and exposure to regulatory and capital-cost pressures. On balance, it's a premium hospital play with long-term appeal.